Source: http://www.google.se/patents/US9492320
Timestamp: 2017-10-19 03:29:30
Document Index: 17886440

Matched Legal Cases: ['§ 256', '§ 1', '§ 256', '§ 1', '§ 256', '§ 1', '§ 1']

Patent US9492320 - Shunt device and method for treating ocular disorders - Google Patent
Shunt devices and a method for continuously decompressing elevated intraocular pressure in eyes affected by glaucoma by diverting excess aqueous humor from the anterior chamber of the eye into Schlemm's canal where post-operative patency can be maintained with an indwelling shunt device which surgically...http://www.google.se/patents/US9492320?utm_source=gb-gplus-sharePatent US9492320 - Shunt device and method for treating ocular disorders
Publikationsnummer US9492320 B2
Ansökningsnummer US 14/316,605
Registreringsdatum 26 jun 2014
Prioritetsdatum 26 apr 1999
Även publicerat som CA2368314A1, CA2368335A1, CA2368335C, CA2368342A1, CA2368354A1, CA2368354C, CA2648346A1, CA2648346C, CN1354642A, DE60019740D1, DE60019740T2, DE60025715D1, DE60025715T2, DE60037406D1, DE60037406T2, DE60042853D1, EP1173123A1, EP1173124A1, EP1173124B1, EP1173125A1, EP1173125B1, EP1173126A1, EP1173126B1, EP1477146A2, EP1477146A3, EP1477146B1, EP2027837A2, EP2027837A3, EP2027837B1, EP2116215A2, EP2116215A3, EP2116215B1, EP2260804A2, EP2260804A3, EP2260804B1, EP3141226A1, US6450984, US6464724, US6524275, US6626858, US6783544, US6827699, US6827700, US7850637, US8152752, US8388568, US8771217, US20030009124, US20030069637, US20030220602, US20030220603, US20030236484, US20040260228, US20050090806, US20050090807, US20100004580, US20110196281, US20150148730, US20170216095, WO2000064389A1, WO2000064390A1, WO2000064390A9, WO2000064391A1, WO2000064393A1
Publikationsnummer 14316605, 316605, US 9492320 B2, US 9492320B2, US-B2-9492320, US9492320 B2, US9492320B2
Uppfinnare Mary G. Lynch, Reay H. Brown
Citat från patent (584), Citat från andra källor (196), Klassificeringar (13), Juridiska händelser (1)
US 9492320 B2
1. An ocular implant configured to maintain patency of Schlemm's canal of an eye in a stenting fashion, the ocular implant comprising:
a body of biocompatible material of a size and shape adapted to facilitate the passage of aqueous humor into and across a trabecular meshwork of the eye;
the body having a length and shape adapted to be circumferentially retained within a portion of Schlemm's canal,
wherein the body is curved,
wherein the body is non-tubular, and
wherein the body comprises at least one opening configured to facilitate passage of aqueous humor.
2. The ocular implant of claim 1, wherein the body comprises a curve having a radius between 3 mm and 10 mm.
3. The ocular implant of claim 1, wherein the body has a length of between 1 mm and 20 mm.
4. The ocular implant of claim 1, wherein the body has an outer cross-sectional dimension of between 0.1 mm and 0.5 mm.
5. The ocular implant of claim 1, wherein the body comprises a first elongated edge and a second elongated edge, and wherein the first elongated edge and the second elongated edge are configured to contact an internal surface of Schlemm's canal when the ocular implant is implanted within Schlemm's canal.
6. The ocular implant of claim 1, wherein at least a portion of the body is trough-like.
7. The ocular implant of claim 6, wherein the portion of the body which is trough-like is configured to open towards collecting channels of the eye.
8. The ocular implant of claim 1, wherein the body is non-lumenal.
9. The ocular implant of claim 1, wherein the at least one opening comprises a portal.
10. The ocular implant of claim 1, wherein the at least one opening comprises at least one fenestration.
11. An ocular implant configured to maintain patency of Schlemm's canal in a stenting fashion, the ocular implant comprising:
a body of biocompatible material of a size and shape adapted to be circumferentially retained within a portion of Schlemm's canal,
wherein the body is non-tubular
wherein the body is curved, and
12. The ocular implant of claim 11, wherein the body comprises a curve having a radius of between 3 mm and 10 mm.
13. The ocular implant of claim 11, wherein the body has a length of between 1 mm and 20 mm.
14. The ocular implant of claim 11, wherein the body has an outer cross-sectional dimension of between 0.1 mm and 0.5 mm.
15. The ocular implant of claim 11, wherein at least a portion of the body is trough-like and non-lumenal.
16. The ocular implant of claim 15, wherein the portion of the body which is trough-like and non-lumenal is configured to open towards collecting channels of the eye.
17. The ocular implant of claim 11, wherein the body comprises a first elongated edge and a second elongated edge, and wherein the first elongated edge and the second elongated edge are configured to contact an internal surface of Schlemm's canal when the ocular implant is implanted within Schlemm's canal.
18. The ocular implant of claim 11, wherein the at least one opening comprises a portal.
19. The ocular implant of claim 11, wherein the at least one opening comprises at least one fenestration.
20. A shunt for implantation within an eye, the shunt comprising:
a non-tubular curved body disposed between the proximal end and the distal end, the curved body comprising a first edge disposed on a first side of a longitudinal axis of the curved body and a second edge disposed on a second side of a longitudinal axis of the curved body; and
a portal positioned at a location between the proximal end and the distal end along the curved body,
wherein at least the curved body is configured to be received circumferentially within a portion of Schlemm's canal of the eye.
21. The shunt of claim 20, wherein the portal is configured to open towards the collecting channels of the eye when the shunt is implanted within Schlemm's canal.
22. The shunt of claim 20, wherein the curved body has a pre-formed curvature to approximate a radius of Schlemm's canal.
23. The shunt of claim 20, wherein the curved body comprises a flexible material.
24. The shunt of claim 20, wherein the portal is ovoid in shape.
25. The shunt of claim 20, wherein the curved body comprises a partially-open, trough-like channel extending from the proximal end to the distal end.
26. The ocular implant of claim 25, wherein the partially-open, trough-like channel is configured to open towards collecting channels of the eye.
27. The shunt of claim 20, wherein the outer cross-sectional dimension of the curved body is between 0.1 mm and 0.5 mm.
28. The shunt of claim 20, wherein the length of the curved body is between 1 mm and 40 mm.
29. The shunt of claim 20, wherein the portal extends through an entire thickness of the curved body.
Furthermore, the proximal portion 10 may be positioned sufficiently remote from the iris 40 to prevent interference therewith such as by traversing a more anterior aspect of the trabecular meshwork into the peripheral corneal tissue. In yet another possible embodiment, as shown in FIG. 6C, the device 100 may comprise a proximal portion 10 in which the terminal aspect of said proximal portion 10 is curved or angled toward the iris 40, and with a, blunted, sealed tip 16 and a portal 18 oriented anteriorly to face away from the underlying iris 40. Such a configuration would tend to decrease the possibility of occlusion of the shunt device by the iris 40.
US6623283 20 dec 2001 23 sep 2003 Autosplice, Inc. Connector with base having channels to facilitate surface mount solder attachment
US6666213 3 jun 2002 23 dec 2003 Aleksandr Igorevich Svadovskiy Method for treating glaucoma
US8034105 16 dec 2005 11 okt 2011 Iscience Interventional Corporation Ophthalmic implant for treatment of glaucoma
US8267882 * 5 mar 2009 18 sep 2012 Ivantis, Inc. Methods and apparatus for treating glaucoma
US8439972 * 26 sep 2011 14 maj 2013 Sight Sciences, Inc. Intraocular implants and related kits and methods
US20020156413 27 apr 1999 24 okt 2002 Stuart K. Williams Glaucoma shunt and a method of making and surgically implanting the same
US20020169468 9 jan 2001 14 nov 2002 J.David Brown Glaucoma treatment device and method
US20020193725 13 jun 2002 19 dec 2002 Odrich Steven A. Injectable glaucoma device
US20030153863 13 feb 2002 14 aug 2003 Patel Anilbhai S. Implant system for glaucoma surgery
US20040000499 26 jun 2002 1 jan 2004 Maiola Anthony Walter Package for surgical implant
US20040076676 21 feb 2002 22 apr 2004 Kakuji Tojo Drug-releasing system of biodegradable polymer type
US20040092856 31 aug 2001 13 maj 2004 Elie Dahan Glaucoma drain
US20040210181 26 apr 2002 21 okt 2004 Clemens Vass Drainage implant for draining aqueous humour from the anterior aqueous chamber of the eye into schlemm's canal
US20050184004 24 feb 2005 25 aug 2005 Rodgers M. S. Glaucoma implant having MEMS filter module
US20050267397 17 maj 2005 1 dec 2005 Ajay Bhalla Aqueous drainage and flow regulating implant
US20060036207 23 aug 2005 16 feb 2006 Koonmen James P System and method for treating glaucoma
US20060079828 18 apr 2005 13 apr 2006 Brown J D Glaucoma treatment device and method
US20060235367 18 dec 2003 19 okt 2006 Seisuke Takashima Aqueous humor drainage implant for treatment glaucoma
US20060276739 19 dec 2005 7 dec 2006 Brown J D Glaucoma treatment device and method
US20070112292 13 nov 2006 17 maj 2007 Hosheng Tu Glaucoma stent and methods thereof for glaucoma treatment
US20070185468 18 okt 2006 9 aug 2007 Prywes Arnold S Method for fluid control in medical applications
US20070260201 2 maj 2007 8 nov 2007 Georgia Tech Research Corporation Method for drug delivery to ocular tissue using microneedle
US20070292474 31 maj 2007 20 dec 2007 Life Spring Biotech Co., Ltd. Structure for modulating intraocular pressure
US20080243247 24 apr 2008 2 okt 2008 Poley Brooks J Method and apparatus for prevention and treatment of adult glaucoma
US20100056977 26 aug 2008 4 mar 2010 Thaddeus Wandel Trans-corneal shunt and method
US20100106073 4 jan 2010 29 apr 2010 Glaukos Corporation Method of monitoring intraocular pressure and treating an ocular disorder
US20100125237 20 nov 2008 20 maj 2010 Schocket Stanley S Implant for use in surgery for glaucoma and a method
US20100168644 23 dec 2009 1 jul 2010 Brown J David Glaucoma Treatment Device and Method
US20100222733 6 maj 2010 2 sep 2010 Schieber Andrew T Glaucoma Treatment Method
US20110144559 16 jun 2010 16 jun 2011 Khalid Lafdi Medical drainage devices with carbon-based structures for inhibiting growth of fibroblasts
US20110245753 5 apr 2011 6 okt 2011 Sunalp Murad A Apparatus and method for lowering intraocular pressure in an eye
US20120010702 15 sep 2011 12 jan 2012 Iscience Interventional Corporation Ophthalmic implant for treatment of glaucoma
US20120130467 26 jul 2010 24 maj 2012 Selden Nathan R Interfacial stent and method of maintaining patency of surgical fenestrations
US20120179087 21 mar 2012 12 jul 2012 Schieber Andrew T Glaucoma Treatment Method
US20120184892 12 jan 2012 19 jul 2012 Ecole Polytechnique Federale De Lausanne (Epfl) Apparatus and methods for treating excess intraocular fluid
US20120203160 12 okt 2010 9 aug 2012 The Regents Of The University Of Colorado, A Body Corporate Implants for reducing intraocular pressure
US20120302861 27 apr 2012 29 nov 2012 Istar Medical Device and method for glaucoma management and treatment
US20120310072 2 jun 2011 6 dec 2012 Grieshaber Ophthalmic Research Foundation Method and device for the pathology analysis of the schlemm's canal
US20130102949 13 dec 2012 25 apr 2013 Abbott Medical Optics Inc. Glaucoma drainage shunts and methods of use
US20140046437 6 aug 2013 13 feb 2014 RegenEye, L.L.C. Ocular Collar Stent for Treating Narrowing of the Irideocorneal Angle
US20150148730 26 jun 2014 28 maj 2015 Glaukos Corporation Shunt device and method for treating ocular disorders
US20150223981 10 nov 2014 13 aug 2015 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
AU2009251058B2 Ingen titel tillgänglig
CA2442652C 8 apr 2002 4 jan 2011 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
CA2683224C 8 apr 2002 2 dec 2014 Glaukos Corporation System and methods thereof for treatment of ocular disorders
EP0858788B1 31 jan 1998 19 maj 2004 Heidelberg Engineering Optische Messsysteme GmbH Medical device, especially for reducing the intraocular pressure
EP1977724A1 8 apr 2002 8 okt 2008 Glaukos Corporation System for treating ocular disorders
EP2263621A1 8 apr 2002 22 dec 2010 Glaukos Corporation System for treating ocular disorders
JP3703721B2 Ingen titel tillgänglig
JP4688444B2 Ingen titel tillgänglig
JP5255402B2 Ingen titel tillgänglig
JP5323011B2 Ingen titel tillgänglig
WO1992000112A1 25 jun 1990 9 jan 1992 Ungerleider Bruce A Apparatus for reducing intraocular pressure
WO2001041685A3 11 dec 2000 3 jan 2002 Iscience Corp Treatment of ocular disease
WO2001050943A3 5 jan 2001 3 jan 2002 Becton Dickinson Co Systems and methods for reducing intraocular pressure
WO2001097727A1 6 jun 2001 27 dec 2001 Glaukos Corporation Stented trabecular shunt and methods thereof
WO2002036052A1 8 maj 2001 10 maj 2002 Glaukos Corporation Glaucoma treatment device
WO2002074052A3 18 mar 2002 22 maj 2003 Glaukos Corp Applicator and methods for placing a trabecular shunt for glaucoma treatment
WO2002080811A9 8 apr 2002 10 apr 2003 Glaukos Corp Glaucoma stent and methods thereof for glaucoma treatment
WO2003015659A3 16 aug 2002 1 maj 2003 Gmp Vision Solutions Inc Improved shunt device and method for treating glaucoma
WO2012071476A2 22 nov 2011 31 maj 2012 David Haffner Drug eluting ocular implant
1 "Changing Perspectives in Glaucoma Management," Innovations in Glaucoma 2010.
2 "Transcend Medical CyPass® System-Instructions for Use," (Release date Apr. 29, 2013).
3 Amendment Accompanying Request for Continued Examination and Response to Office Action dated Mar. 16, 2010, filed in U.S. Appl. No. 10/987,114 (Jun. 15, 2010)(12 pages).
4 Anselm Kampik and Franz Grehn, Nutzen und Risiken augenärztlicher Therapie, Hauptreferate der XXXIII. Essener Fortbildung für Augenärzte, Dec. 1998. (English translated version enclosed Benefits and Risks of Ophthalmological Therapy.)
5 Answer and Counterclaim (May 31, 2013).
6 Answer and Counterclaim, Filed Jan. 3, 2014.
7 Arthur L. Schwartz, MD, and Douglas R. Anderson, MD, Trabecular Surgery, Arch Ophthalmol, vol. 92, Aug. 1974, pp. 134-138.
8 Beck and Lynch, "360° Trabeculotomy for Primary Glaucoma," Arch. Ophthalmol. 113 (Sep. 1995), pp. 1200-1202.
9 Buskirk et al., "Lens Depression and Aqueous Outflow in Enucleated Primate Eyes," American Journal of Ophthalmology, vol. 76, No. 5, Nov. 1973, pp. 632-640.
10 Buskirk et al., "Trabeculotomy in the immature, enucleated human eye," Invest. Ophthalmol. Visual Sci., vol. 6, No. 1, Jan. 1977, pp. 63-66.
11 Cindy K. Bahler, BS, Gegrory T. Smedley, PhD, Jianbo Zhou, PhD, Douglas H. Johnson, MD., American Journal of Ophthalmology, Dec. 2004, vol. 138.
12 Communication from European Patent Office for European App. No. 08102896.1 (Jul. 2, 2012) (5 pages).
13 Communication of the Board of Appeal Pursuant to Article 15(1) of the Rules of Procedure of the Boards of Appeal, submitted in the prosecution history of EP1977724, dated May 8, 2014 (Board of Appeal Communication, EP1977724.
14 Complaint for Declaratory Judgment of Patent Non-Infringement and Invalidity (May 10, 2013).
15 Complaint for Judgment of Patent Non-Infringement and Invalidity (May 10, 2013).
16 Correspondence from the U.S. Patent and Trademark Office granting the petition to correct inventorship, filed in the prosecution history of U.S. Pat. No. 7,857,782 (dated Nov. 18, 2014).
17 Correspondence from the U.S. Patent and Trademark Office granting the petition to correct inventorship, filed in the prosecution history of U.S. Pat. No. 8,075,511 (dated Oct. 31, 2014).
18 Correspondence from the U.S. Patent and Trademark Office granting the petition to correct inventorship, filed in the prosecution history of U.S. Pat. No. 8,579,846 (dated Feb. 10, 2015).
19 Daniel A. Fletcher, Ph.D., Daniel V. Palanker, Ph.D., Philip Hule, M.D., Jason Miller, MS, Michael F. Marmor, M.D. and Mark S. Blumenkranz, M.D.; Intravascular Drug Delivery With a Pulsed Liquid Microjet; (Reprinted) Arch Ophthalmology; vol. 120, Sep. 2002, pp. 1206-1208.
20 Decision of Technical Board of Appeal 3.2.08 of Jan. 15, 2015, submitted in the prosecution history of EP1977724, dated Jan. 15, 2015.
21 Declaration of Alyse Katz in Support of Motion for Summary Judgment of Invalidity dated Jun. 19, 2015 [Redacted-Public Version].
22 Declaration of Alyse L. Katz in Support of Transcend's Reply in Support of its Motion for Summary Judgment of Invalidity [Redacted-Public Version].
23 Declaration of Dr. L. Jay Katz in Support of Glaukos's Opening Claim Construction Brief, Jul. 17, 2014, 78 pages.
24 Declaration of Du Vergier in Support of Transcend's Motion for Summary Judgment of Non-Infringement dated Jun. 19, 2015 [Redacted-Public Version].
25 Declaration of John Richards in Support of Glaukos's Opposition to Transcend's Motion for Summary Judgment of Invalidity dated Jul. 2, 2015.
26 Declaration of Joseph F. Jennings in Support of Glaukos's Opening Claim Construction Brief, Jul. 18, 2014, 78 pages.
27 Declaration of Joseph F. Jennings in Support of Glaukos's Opposition to Transcend's Motion for Summary Judgment of Non-Infringement dated Jul. 9, 2015 [Redacted-Public Version].
28 Declaration of Joshua Stowell in Support of Glaukos's Motion for Summary Judgment on Transcend's Third Cause of Action for a Declaratory Judgment of Unenforceability for Inequitable Conduct dated Jun. 19, 2015 [Redacted-Public Version].
29 Declaration of Joshua Stowell in Support of Glaukos's Opposition to Transcend's Motion for Summary Judgment of Invalidity dated Jul. 9, 2015 [Redacted-Public Version].
30 Declaration of Julien Du Vergier in Support of Transcend's Opposition to Glaukos' Motion for Summary Judgment of No Inequitable Conduct dated Jul. 9, 2015 [Redacted-Public Version].
31 Declaration of Julien Du Vergier in Support of Transcend's Reply in Support of its Motion for Summary Judgment of Non-Infringement dated Jul. 17, 2015 [Redacted-Public Version].
32 Declaration of L. Jay Katz in Support of Glaukos's Oppositions to Transcend's Motions for Summary Judgment of Non-Infringement and Invalidity dated Jul. 9, 2015 [Redacted-Public Version].
33 Declaration of Richard Lewis M.D. in Support of Glaukos's Oppositions to Transcend's Motions for Summary Judgment of Non-Infringement and Invalidity dated Jul. 2, 2015.
34 Declaration of Ron Yamamoto in Support of Glaukos's Opposition to Transcend's Motion for Summary Judgment of Invalidity dated Jul. 2, 2015.
35 Declaration of Vasquez in Support of Transcend's Motion for Summary Judgment of Non-Infringement dated Jun. 19, 2015 [Redacted-Public Version].
36 Demailly, P., et al., "Non-Penetrating Deep Sclerectomy Combined With a Collagen Implant in Primary Open-Angle Glaucoma. Medium-Term Retrospective Results", J. Fr. Ophthalmol., vol. 19, No. 11, 1996, pp. 659-666. (abstract only).
37 Deposition Jay Katz Dated Jun. 10, 2015.
38 Deposition Jay Katz, Dated Oct. 1, 2014.
39 Deposition of John Richards, Dated Jun. 17, 2015.
40 Deposition Transcript of M. Bruce Shields dated Jun. 3, 2015 [Redacted-Public Version].
41 Detlev Spiegel, 7 Chirurgische Glaukomtherapie, pp. 79-88.
42 Detlev Spiegel, MD, Karin Kobuch, MD, Richard A. Hill, MD, Ronald L. Gross, MD, Schlemm's Canal Implant: A New Method to Lower Intraocular Pressure in Patients With POAG, Ophthalmic Surgery and Lasers, Jun. 1999, vol. 30, No. 6, pp. 492-494.
43 Duane's Ophthalmology on CD-ROM, 2006 Edition, Chapter 56-Medical Therapy of Glaucoma by Marc Weitzman and Joseph Caprioli.
44 Edited by Kevin Strange, Cellular and Molecular Physiology of Cell Volume Regulation, Library of Congress Cataloging in-Publication Data, CRC Press, Inc., pp. 312-321.
45 Excerpt from the prosecution history of U.S. Appl. No. 09/549,350, including the Inventor Declaration (dated Aug./Sep. 2000).
46 Excerpt from the prosecution history of U.S. Appl. No. 09/704,276, including the Inventor Declaration (dated Feb. 2001).
47 Excerpt from the prosecution history of U.S. Pat. No. 7,857,782, including the Inventor Declaration dated Jun. 14, 2002.
48 Excerpt from the prosecution history of U.S. Pat. No. 8,075,511, including the Inventor Declaration dated Jun. 14, 2002.
49 Excerpt from the prosecution history of U.S. Pat. No. 8,579,846, including the Inventor Declaration dated Jun. 14, 2002.
50 Excerpt of Ramesh C. Tripathi & Brenda J. Tripathi, Chapter 1: Anatomy of the Human Eye, Orbit, and Adnexa, in Ramesh C. Tripathi & Brenda J. Tripathi, The Eye (Academic Press, Inc. 1984).
51 Excerpt of the transcript from the deposition of David Schetter on Dec. 18, 2014.
52 Excerpt of Transcend's First Set of Interrogatories to Defendant Glaukos Corporation dated Jul. 16, 2013.
53 Excerpt of Transcend's First Set of Requests for Production to Defendant Glaukos Corporation dated Jul. 16, 2013.
54 Excerpts from the certified Deposition Transcript of Barbara Niksch, dated Jun. 6, 2014.
55 Excerpts from the certified Deposition Transcript of David Haffner, dated May 28, 2014.
56 Excerpts from the certified Deposition Transcript of Gregory Smedley, Ph.D., Aug. 6, 2014, pp. 1, 3-4, 6-7, 12, 99-102, 106-114, and 203.
57 Excerpts from the certified Deposition Transcript of Joseph Caprioli, M.D., dated May 27, 2015.
58 Excerpts from the certified Deposition Transcript of Richard A. Hill, M.D., Jul. 17, 2014, pp. 1, 3-4, 240-253, and 270.
59 Excerpts from the certified Deposition Transcript of Richard Lewis, M.D., dated Jun. 5, 2015.
60 Excerpts from the certified Deposition Transcript of Ron Yamamoto, dated May 22, 2015.
61 Excerpts from the file history of U.S. Pat. No. 7,563,241 dated Mar. 13, 2009.
62 Expert Report of Harold (Hal) J. Walbrink Regarding the Invalidity of Various Claims of the Patents in Suit and the Obviousness of Certain Claim Elements (Mar. 9, 2015) (63 pages).
63 Expert Report of Richard Lewis, M.D. (Mar. 9, 2015) (79 pages).
64 Expert Supplemental Report of Harold (Hal) J. Walbrink Regarding the Invalidity of Various Claims of The Patents-in-suit and the Obviousness of Certain Claim Elements (May 8, 2015) (17 pages).
65 Fine et al., "A Clinicopathologic Study of Four Cases of Primary Open-Angle Glaucoma Compared to Normal Eyes", American Journal of Ophthalmology, vol. 91, No. 1, 1981, pp. 88-105.
66 First Amended Complaint for Declaratory Judgment of Patent Non-Infringement and Invalidity, Filed Dec. 16, 2013.
67 Gharagozloo et al., "Unilateral Exfoliation Syndrome Without Glaucoma-A Comparison of Aqueous Dynamica Between Affected and Normal Eyes", Glaucoma Paper Presentation, (abstract only-not dated).
68 Glaukos Corporation's Initial Disclosures, Served Jul. 30, 2013.
69 Glaukos Corporation's Objections and Responses to Transcend Medical, Inc.'s First Set of Requests for Admission dated Aug. 29, 2014.
70 Glaukos Corporation's Redacted Answer and Counterclaims to the Second Amended Complaint for Declaratory Judgment, Sep. 29, 2014, 27 pages.
71 Glaukos Corporation's Reply Claim Construction Brief, Aug. 29, 2014, 14 pages.
72 Glaukos Corporation's Responses to Transcend Medical, Inc.'s First Set of Interrogatories (Nos. 1-11) (Aug. 15, 2013).
73 Glaukos Corporation's Responses to Transcend Medical, Inc.'s Fourth Set of Interrogatories (Nos. 14-15) dated Aug. 29, 2014.
74 Glaukos Corporation's Responses to Transcend Medical, Inc.'s Second Set of Interrogatories (No. 12) dated Jun. 26, 2014.
75 Glaukos Corporation's Responses to Transcend Medical, Inc.'s Sixth Set of Interrogatories (Nos. 20-25) dated Nov. 21, 2014.
76 Glaukos Corporation's Responses to Transcend Medical, Inc.'s Third Set of Interrogatories (No. 13) dated Jul. 7, 2014.
77 Glaukos Corporation's Supplemental Disclosures, Served Oct. 29, 2014.
78 Glaukos Corporation's Supplemental Response to Transcend Medical, Inc.'s Interrogatory No. 3 dated Aug. 29, 2014.
79 Glaukos Corporation's Supplemental Response to Transcend Medical, Inc.'s Third Set of Interrogatories (No. 13) dated Nov. 21, 2014.
80 Glaukos' Opening Claim Construction Brief, Jul. 18, 2014, 30 pages.
81 Glaukos's Motion for Summary Judgment on Transcend's Third Cause of Action for a Declaratory Judgment of Unenforceability for Inequitable Conduct dated Jun. 12, 2015.
82 Glaukos's Opening Brief in Support of Glaukos's Motion for Summary Judgment on Transcend's Third Cause of Action for a Declaratory Judgment of Unenforceability for Inequitable Conduct dated Jun. 12, 2015.
83 Glaukos's Opposition to Transcend's Motion for Summary Judgment of Invalidity dated Jul. 2, 2015.
84 Glaukos's Opposition to Transcend's Motion for Summary Judgment of Non-Infringement dated Jul. 9, 2015 [Redacted-Public Version].
85 Glaukos's Reply in Support of its Motion for Summary Judgment on Transcend's Third Cause of Action for a Declaratory Judgment of Unenforceability for Inequitable Conduct dated Jul. 17, 2015 [Redacted-Public Version].
86 Glaukos's Statement of Material Facts that Present Genuine Issues for Trial in Opposition to Transcend's Motion for Summary Judgment of Invalidity dated Jul. 9, 2015 [Redacted-Public Version].
87 Glaukos's Statement of Material Facts that Present Genuine Issues for Trial in Opposition to Transcend's Motion for Summary Judgment of Non-Infringement dated Jul. 9, 2015 [Redacted-Public Version].
88 Glaukos's Statement of Undisputed Material Fact dated Jun. 12, 2015.
89 Hady Saheb et al., Optical Coherence Tomography of the Suprachoroid After CyPass Micro-Stent Implantation for the Treatment of Open-Angle Glaucoma, Br. J. Ophthalmology, 98:19-23 (2014).
90 Hamard, P., et al., "Deep Nonpenetrating Sclerectomy and Open Angle Glaucoma. Intermediate Results From Thbe First Operated Patients", J. Fr. Ophthalmol., vol. 22 (j), Feb. 1999, pp. 25-31, (abstract only).
91 Hans Hoerauf, Christopher Wirbelauer, Christian Scholz, Ralf Engelhardt, Peter Koch, Horst Lague, and Reginald Birngruber, Slit-Lamp-Adapted Optical Coherence Tomography of the Anteriuor Segment, Graefe's Arch Clin. Exp. Ophthalmol, May 1999, vol. 238, pp. 8-18.
92 Helmut Hoeh et al., Early Postoperative Safety and Surgical Outcomes After Implantation of a Suprachoroidal Micro-Stent for the Treatment of Open-Angle Glaucoma Concomitant with Cataract Surgery, 39 J. Cataract Refract. Surg. 431 (2013).
93 Histology of the Human Eye, An Atlas and Textbook, Chapter Eight: Choroid (1971) (74 pages).
94 Hoskins, H. Dunbar, et al., Diagnosis and Therapy of the Glaucomas, Chapter 4: Aqueous Humor Outflow, 6th edition, pp. 41-66 (1989) (28 pages).
95 I. Grierson, R.C. Howes, and Q. Wang, Age-related Changes in the Canal of Schlemm, Exp. Eye Res., 1984, vol. 39, pp. 505-512.
96 Improving the Flow: A Survey of Available Implants, EW Practice Managment, Oct. 11, 1999, website "http://www.eyeworld.org/tooltime/999inserts.asp".
97 Jianbo Zhou, PhD, Gregory T. Smedley, PhD., A Trabecular Bypass Flow Hypothesis, Feb. 2005, vol. 14 No. 1.
98 Johannes W. Rohen, Glaucoma, vol. 1, Chapter 14, Anatomy of the Aqueous Outflow Channels, Grune & Stratton, Harcourt Brace Jovanovich Publishers, edited by J.E. Cairns, pp. 277-296.
99 Johnson, M.C. and R. D. Kamm, The Role of Schlemm's Canal in Aqueous Outflow from the Human Eye, Investigative Ophthalmology & Visual Science, Mar. 1983, vol. 24, pp. 321-325.
100 Joint Claim Construction Statement, Filed Jun. 20, 2014.
101 Karlen, M.E., et al., "Deep Sclerectomy With Collagen Implant: Medium Term Results", Br. J. Ophthalmol. vol. 83, No. 1, Jan. 1999, pp. 6-11, (abstract only).
102 L. Jay Katz, Ciliochoroidal Detachment, 18:3 Ophthalmic Surgery 175, (Mar. 1987).
103 L. Jay Katz, M.D., A Call for Innovative Operations for Glaucoma, Arch Ophthalmology, Mar. 2000, vol. 118, pp. 412-413.
104 Luanna K. Putney, Cecile Rose T. Vibat, and Martha E. O'Donnell, Intracellular C1 Regulates Na-K-C1 Cotransport Activity in Human Trabecular Meshwork Cells, 1999 American Physiological Society, Sep. 1999, pp. C373 through C383.
105 M. Bruce Shields, MD, A Study Guide for Glaucoma: Aqueous Humor Dynamics, Copyright 1982, pp. 6-43.
106 M.A. Johnstone, R. Stegmann, and B.A. Smit, American Glaucoma Society, 12th Annual Meeting, Cylindrical Tubular Structures Spanning from Trabecular Meshwork Across SC, Laboratory Studies with SEM, TEM and Tracers Correlated with Clinical Findings, p. 39.
107 Markman Hearing Transcript before Honorable Mitchell S. Goldberg, Dated Nov. 13, 2014.
108 Maurice H. Luntz, MD, and D.G. Livingston, B.SC., Trabeculotomy AB Externo and Trabeculectomy in Congenital and Adult-Onset Glaucoma, American Journal of Ophthalmology, Feb. 1977, vol. 83, No. 2, pp. 174-179.
109 McMenamin, et al., "Age-Related Changes in the Human Outflow Apparatus", Ophthalmology, vol. 93, No. 2., Feb. 1986, pp. 194-209.
110 Memorandum Opinion re Claim Construction dated Jan. 16, 2015.
111 Mermoud, A., et al., "Comparison of Deep Sclerectomy With Collagen Implant and Trabeculectomy in Open-Angle Glaucoma", J. Cataracat Refract. Surg., vol. 25, No. 3, Mar. 1999, pp. 323-331, (abstract only).
112 Moses, Robert A. et al., "Blood Reflux in Schlemm's Canal", Arch Ophthamol., vol. 97, Jul. 1979, pp. 1307-1310.
113 Moses, Robert A. M.D., Circumferential Flow in Schlemm's Canal, American Journal of Ophthalmology, Sep. 1979, vol. 88, No. 3, Part II, pp. 585-591.
114 Nir Shoham-Hazon et al., "Stability and Predictive Value of OCT Findings After CyPass Suprachoroidal Micro-Stent Implantation," available at: http://transcendmedical.com/wp-content/uploads/2014/12/TM-AGS-2012-F2-final.pdf (last visited Jun. 12, 2015).
115 Notice of Allowability in U.S. Appl. No. 10/987,114 (Jul. 29, 2010)(3 pages).
116 Notice of Allowance issued by the USPTO from the file history of U.S. Pat. No. 8,579,846 (signed by Examiner Jul. 31, 2013).
117 Office Action from the USPTO dated Jun. 28, 2010 and Glaukos's response to that Office Action from the file history of U.S. Pat. No. 8,075,511.
118 Office Action from the USPTO dated Sep. 18, 2009 and Glaukos's response to that Office Action from the file history of U.S. Pat. No. 8,075,511.
119 Order re Claim Construction dated Jan. 16, 2015.
120 Petition to Correct Inventorship in a Patent Pursuant to 35 U.S.C. § 256 and 37 C.F.R. § 1.324, filed in the prosecution history of U.S. Pat. No. 7,857,782 dated May 2014.
121 Petition to Correct Inventorship in a Patent Pursuant to 35 U.S.C. § 256 and 37 C.F.R. § 1.324, filed in the prosecution history of U.S. Pat. No. 8,075,511 dated May 2014.
122 Petition to Correct Inventorship in a Patent Pursuant to 35 U.S.C. § 256 and 37 C.F.R. § 1.324, filed in the prosecution history of U.S. Pat. No. 8,579,846 dated May 2014.
123 Philip C. Jacobi, MD, Thomas S. Dietlein, MD, and Gunter K. Krieglstein, MD., Bimanual Trabecular Aspiration in Pseudoexfoliation Glaucoma, Ophthalmology, 1998, vol. 105, No. 5, May 1998, pp. 886-894.
124 Phillip C. Jacobi, MD, Thomas S. Dietlein, MD, and Gunter K. Krieglstein, MD., Goniocurettage for Removing Trabecular Meshwork: Clinical Results of a New Surgical Technique in Advanced Cronic Open-Angle Glaucoma, American Journal of Ophthalmology, May 1999, pp. 505-510.
125 Phillip C. Jacobi, MD, Thomas S. Dietlein, MD, and Gunter K. Krieglstein, MD., Microendoscopic Trabecular Surgery in Glaucoma Management, Ophthalmology, 1999, vol. 106, No. 3, pp. 538-544.
126 Plaintiff Transcend Medical Inc.'s Answer to Counterclaims (Jun. 24, 2013).
127 R.A. Hill, Q. Ren, D.D. Nguyen, L-H Liaw, and M.W. Berns, Free-Electron Laser (FEL) Ablation of Ocular Tissues, Lasesr Med Sci 1998, pp. 13:219-226.
128 Rebuttal Expert Report of John Richards (Apr. 24, 2015) (16 pages).
129 Rebuttal Expert Report of L. Jay Katz MD. (Apr. 24, 2015) (130 pages).
130 Rebuttal Expert Report of Richard Lewis, M.D. (Apr. 24, 2015) (39 pages).
131 Rebuttal Expert Report of Ron Yamamoto (Apr. 24, 2015) (65 pages).
132 Redacted Exhibits A-C of Transcend Medical, Inc.'s First Supplemental Response to Glaukos Corporation's Interrogatory No. 1 dated Dec. 23, 2013.
133 Request for Correction of Inventorship Under 37 C.F.R. § 1.48(d), dated May 27, 2014 and filed in the prosecution history of U.S. Appl. No. 60/281,973.
134 Richard A. Hill, MD, George Baerveldt, MD, Serdar A. Ozler, MD, Michael Pickford, BA, Glen A. Profeta, BS, and Michael W. Berns,PhD, Laser Trabecular Ablation (LTA), Laser in Surgery and Medicine, 1991, vol. 11, pp. 341-346.
135 Richard Hill, MD, "Inventor's Perspective," Glaucoma Today (Nov./Dec. 2012).
136 Robert W. Nickells, Apoptosis of Retinal Ganglion Cells in Glaucoma: An Update of the Molecular Pathways Involved in Cell Death, Survey of Ophthalmology, vol. 43, Supplement 1, Jun. 1999, pp. S-151 through S-161.
137 Robinson, et al., "Superior Cervical Ganglionectomy: Effects on Aqueous Human Flow in the Cynomolgus Monkey", Glaucoma Paper Presentation, (abstract only-not dated).
138 Rosenberg, et al., "Implants in Glaucoma Surgery", The Glaucomas, 1996, Chapter 88, pp. 1783-1807 (27 pages).
139 Samalonis, Lisa B., "New Horizons in the Surgical Treatment of Glaucoma", Ew Glaucoma, Oct. 11, 1999, website "http://www.eyeworld.org/sep99/999p62.asp".
140 Schocket, Investigations of the Reasons for Success and Failure in the Anterior Shunt-to-the Encircling-Band Procedure in the Treatment of Refractory Glaucoma, Tr. Am. Ophth. Soc., 84:743 (1986).
141 Second Declaration of Joshua Stowell in Support of Glaukos's Motion for Summary Judgment on Transcend's Third Cause of Action for a Declaratory Judgment of Unenforceability for Inequitable Conduct dated Jul. 17, 2015 [Redacted-Public Version].
142 Sherman, Steven H., et al., "The Fate of Anterior Chamber Fluorescein in the Monkey Eye 1. The Anterior Chamber Outflow Pathways", Exp. Eye Res. vol. 27, pp. 159-173 (1978) (15 pages).
143 Shields, M. Bruce, Textbook of Glaucoma, Fourth Ed., Williams & Wilkins Publishers, 1998, pp. 5-31.
144 Subpoena to Produce Documents, Information, or Objects or to Permit Inspection of Premises in a Civil Action propounded on Dr. Richard A. Hill, Feb. 11, 2014.
145 Sumita Radhakrishnan, Andrew M. Rollins, Jonathan E. Roth, S. Yazddanfar, Volker Westphal, David Bardenstein, and Joseph lzatt, Real-Time Optical Coherence Tomography of the Anterior Segment at 1310 nm, Arch Ophthalmology, Aug. 2001, vol. 119, pp. 1179-1185.
146 Tin A. Tun et al., Assessment of Trabecular Meshwork Width Using Swept Source Optical Coherence Tomography, 251:6 Graefes Arch. Clin. Exp. Ophthalmol. 1587 (2013).
147 Tin A. Tun et al.,"Measurement of Trabecular Meshwork Width Using Swept Source Optical Coherence Tomography-Abstract" (May 2012), available at: http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=6e904fa6-4f1b-406a-8fd9-3ad7551c527d&cKey=80031868-31bf-4b5e-8043-d3e5aedc7bf0 (last visited Jun. 12, 2015).
148 Transcend Medical, Inc.'s Answer to Counterclaims, Served Jan. 13, 2014.
149 Transcend Medical, Inc.'s Disclosures Pursuant to Default Discovery Rule 4(d) (Dec. 6, 2013) (341 pages).
150 Transcend Medical, Inc.'s First Supplemental Response to Glaukos Corporation's Interrogatory No. 1 dated Dec. 23, 2013.
151 Transcend Medical, Inc.'s Initial Disclosures, Served Jul. 30, 2013.
152 Transcend Medical, Inc.'s Redacted Exhibit A to the Stipulation and Proposed Order for Second Amended Complaint and Amendment of Scheduling Order, Sep. 11, 2014, 205 pages.
153 Transcend Medical, Inc.'s Redacted Second Amended Complaint for Declaratory Judgment of Patent Non-Infringement, Invalidity and Unenforceability, Sep. 10, 2014, 206 pages.
154 Transcend Medical, Inc.'s Responses and Objections to Glaukos Corporation's First Set of Interrogatories dated Oct. 24, 2013.
155 Transcend Medical, Inc.'s Responses and Objections to Glaukos Corporation's First Set of Requests for Admission, Served Aug. 29, 2014.
156 Transcend Medical, Inc.'s Responses and Objections to Glaukos Corporation's Fourth Set of Interrogatories, Served Aug. 29, 2014 [Redacted-Public Version].
157 Transcend Medical, Inc.'s Responses and Objections to Glaukos Corporation's Second Set of Interrogatories dated May 27, 2014.
158 Transcend Medical, Inc.'s Second Supplemental Invalidity Contentions, Aug. 26, 2014, 39 pages.
159 Transcend Medical, Inc.'s Second Supplemental Response to Glaukos Corporation's Interrogatory No. 1 dated Mar. 3, 2014.
160 Transcend Medical, Inc.'s Supplemental Disclosures, Served Nov. 14, 2014.
161 Transcend Medical, Inc's Redacted Sur-Reply Claim Construction Brief, Sep. 17, 2014, 14 pages.
162 Transcend's Answer to Counterclaims, Oct. 17, 2014, 10 pages.
163 Transcend's First Supplemental Response to Glaukos Corporation's Interrogatory Nos. 17 and 18 dated May 13, 2014.
164 Transcend's Letter to Judge Regarding Citation Errors and Missing Exhibit Pages in Briefing Papers dated Jul. 28, 2015.
165 Transcend's Memorandum in Opposition to Glaukos' Motion for Summary Judgment of No Inequitable Conduct dated Jul. 9, 2015 [Redacted-Public Version].
166 Transcend's Memorandum in Support of Transcend's Motion for Summary Judgment of Invalidity dated Jun. 19, 2015 [Redacted-Public Version].
167 Transcend's Memorandum in Support of Transcend's Motion for Summary Judgment of Non-Infringement dated Jun. 19, 2015 [Redacted-Public Version].
168 Transcend's Motion for Summary Judgment of Invalidity dated Jun. 12, 2015.
169 Transcend's Motion for Summary Judgment of Non-Infringement dated Jun. 12, 2015.
170 Transcend's Reply in Support of its Motion for Summary Judgment of Invalidity dated Jul. 17, 2015 [Redacted-Public Version].
171 Transcend's Reply in Support of its Motion for Summary Judgment of Non-Infringement dated Jul. 17, 2015 [Redacted-Public Version].
172 Transcend's Response and Statement of Further Undisputed Facts in Support of its Opposition to Glaukos' Motion for Summary Judgment of No Inequitable Conduct dated Jul. 9, 2015 [Redacted-Public Version].
173 Transcend's Responses and Objections to Glaukos Corporation's Fifth Set of Interrogatories dated Nov. 20, 2014.
174 Transcend's Statement of Undisputed Facts in Support of Transcend's Motion for Summary Judgment of Invalidity dated Jun. 19, 2015 [Redacted-Public Version].
175 Transcends's Claim Construction Brief, Aug. 15, 2014, 375 pages.
176 Tripathi et al. "Functional Anatomy of the Anterior Chamber Angle", Biomedical Foundations of Ophthalmology, 1(10): 1-74, Ed. Thomas Dune and Edward Jaeger, Revised Ed. 1983, Harper & Row.
177 Troncoso, Manuel U., Tantalum implants for inducing hypotony, American Journal of Ophthalmology, vol. 32, No. 4, Apr. 1949, pp. 499-508.
178 Troncoso, Manuel Uribe, M.D., Cyclodialysis with Insertion of a Metal Implant in the Treatment of Glaucoma, Read before the Section on Ophthalmology at the Ninetieth Annual Session of the American Medical Association, St. Louis, May 17, 1939, Archives of Ophthalmology, pp. 270-300, downloaded from www.archophthalmol.com on Aug. 5, 2010.
179 Tsontcho Ianchulev et al., "Minimally Invasive Ab-Interno Suprachoroidal Device (CyPass) for IOP Control in Open-Angle Glaucoma," presented at the Annual Meeting of the American Academy of Ophthalmology Oct. 16-19, 2010, Chicago, IL.
180 Tsontcho Ianchulev, Chapter 21: The CyPass Suprachoroidal Micro-Stent, in J.R. Samples & I.I.K. Ahmed (eds.), Surgical Innovations in Glaucoma 229 (Springer Science+Business Media 2014).
181 Tsontcho Ianchulev, Chapter 3: Suprachoroidal Space as a Therapeutic Target , in J.R. Samples & I.I.K. Ahmed (eds.), Surgical Innovations in Glaucoma 33 (Springer Science+Business Media 2014).
182 U.S. Appl. No. 09/452,963, filed Dec. 2, 1999. Title: Expandable/ Retractable Stent for Venous and Valvular Annulus Use.
183 U.S. Appl. No. 09/704,276, filed Nov. 1, 2000 [now U.S. Pat. No. 6,736,791].
184 U.S. Appl. No. 60/276,609, filed Mar. 16, 2001.
185 U.S. Clinical Wick Trials, Oct. 11, 1999, website http://www.cornea.org/us.htm.
186 Vincente L. Jocson, M.D.; Air Trabeculotomy; American Journal of Ophthalmolgy: vol. 79, No. 1, Jan.-Jun. 1975; pp. 107-111.
187 W.G. Tatton, Apoptotic Mechanisms in Neurodegeneration: Possible Relevance to Glaucoma, European Journal of Ophthalmology, Jan.-Mar. 1999, vol. 9, Supplement 1, pp. S22 through S29.
188 W.M. Grant, MD, Further Studies on Facility of Flow Through the Trabecular Meshwork, A.M.A. Archives of Ophthalmololgy, Oct. 1958, vol. 60, pp. 523-533.
189 Webpage regarding the definition of "subchoroidal" from Merriam Webster's Medical Dictionary, available at: http://www.merriam-webster.com/medical/subchoroidal (last visited Jun. 11, 2015).
190 Website entitled, "2013 Ophthalmology Innovation Summit Innovator Awards," dated Nov. 14, 2013 available at: http://ois.net/2013-ophthalmology-innovator-award/ (last visited Jun. 29, 2015).
191 Website entitled, "About Glaukos-History," available at: http://www.glaukos.com/about-glaukos/history (last accessed Jun. 29, 2015).
192 Webster's Third New International Dictionary of the English Language (Unabridged), definitions of "deploy" and "deployment", p. 605 (2002) (4 pages).
193 Welsh, N.H., et al., "The 'Deroofing' of Schlemm's Canal in Patients With Open-Angle Glaucoma Through Placement of a Collagen Drainage Device", Ophthalmic Surg. Lasers, vol. 29, No. 3, Mar. 1998, pp. 216-226, (abstract only).
194 William Tatton, Ruth M.E. Chalmers-Redman, Ajay Sud, Steven M. Podos, and Thomas Mittag, Maintaining Mitochondrial Membrane Impermeability: An Opportunity for New Therapy in Glaucoma, Survey of Ophthalmology, vol. 45, Supplement 3, May 2001, pp. S277 through S283.
195 Wilson, Ellen D., "Implants Offer Choices for Glaucoma Surgeons", EW Glaucoma, Oct. 11, 1999, website "http://www.eyeorld.org/sep99/999p60.asp".
196 Yasuhiro Matsumoto and Douglas H. Johnson, Trabecular Meshwork Phagocytosis in Graucomatous Eyes, Ophthalmologica 1977, vol. 211, pp. 147-152.
Internationell klassificering A61F2/84, A61M25/00, A61F9/00, A61F9/007, A61F2/00
Kooperativ klassning A61F2230/0008, A61F9/00781, A61M25/007, A61M25/0074, A61F9/0017, A61M25/0068, A61M2210/0612, A61F2250/0067